
membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-25 23:59
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 6.08 | -12.38% | -62 | ![]() |
0 |
19/02/25 | MEDINCELL SA | Achat | 400 E | 13.46 | 15.05 | 11.60% | 46 | ![]() |
0 |
19/02/25 | VALNEVA SE | Vente | 1 000 E | 3.62 | 2.90 | 17.79% | 178 | ![]() |
0 |
18/02/25 | VALNEVA SE | Vente | 1 000 E | 3.60 | 2.90 | 17.32% | 173 | ![]() |
0 |
19/12/24 | EUROAPI | Vente | 1 000 E | 2.80 | 2.74 | -1.44% | -14 | ![]() |
0 |
18/12/24 | COGELEC SA | Achat | 500 E | 15.10 | 21.80 | 44.13% | 221 | ![]() |
0 |
17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 21.80 | 40.40% | 202 | ![]() |
0 |
17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 21.80 | 40.40% | 202 | ![]() |
0 |
12/11/24 | VALNEVA SE | Vente | 1 000 E | 2.30 | 2.90 | -30.41% | -304 | ![]() |
0 |
06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 15.05 | -1.32% | -5 | ![]() |
0 |
28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 1.09 | -14.36% | -57 | ![]() |
0 |
28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 1.09 | -18.84% | -75 | ![]() |
0 |
22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.86 | -43.11% | -172 | ![]() |
0 |
21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.86 | -36.70% | -147 | ![]() |
0 |
02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.75 | -22.40% | -112 | ![]() |
0 |
02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.75 | -23.76% | -95 | ![]() |
0 |
01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.75 | 7.82% | 31 | ![]() |
0 |
30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 6.08 | -25.14% | -101 | ![]() |
0 |
23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 6.08 | -18.06% | -54 | ![]() |
0 |
19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 6.08 | -21.76% | -87 | ![]() |
0 |
17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 6.08 | -16.14% | -65 | ![]() |
0 |
22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 1.09 | -39.27% | -157 | ![]() |
0 |
05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 1.09 | -52.96% | -212 | ![]() |
0 |
29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.75 | -29.32% | -117 | ![]() |
0 |
29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.75 | -31.27% | -125 | ![]() |
24 |
10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 15.05 | 0.40% | 2 | ![]() |
0 |
10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 15.05 | -0.53% | -2 | ![]() |
0 |
08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.86 | -53.37% | -213 | ![]() |
0 |
25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 6.08 | 32.92% | 132 | ![]() |
0 |
21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.70 | -47.35% | -189 | ![]() |
0 |
18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 1.99 | -15.14% | -61 | ![]() |
0 |
08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 1.09 | -83.24% | -333 | ![]() |
0 |
19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.75 | -26.95% | -135 | ![]() |
0 |
18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.75 | -27.86% | -111 | ![]() |
0 |
14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 1.09 | -74.89% | -300 | ![]() |
0 |
13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 1.99 | -37.97% | -152 | ![]() |
0 |
23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 6.08 | -45.63% | -183 | ![]() |
7 |
23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 1.99 | -67.77% | -271 | ![]() |
7 |
21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 1.99 | -66.52% | -266 | ![]() |
7 |
15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 1.09 | -86.35% | -345 | ![]() |
7 |
14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 1.09 | -86.80% | -347 | ![]() |
5 |
31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.75 | -85.53% | -342 | ![]() |
7 |
16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 1.09 | -86.21% | -345 | ![]() |
7 |
10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 1.09 | -85.70% | -257 | ![]() |
7 |
04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 1.09 | -84.50% | -254 | ![]() |
4 |
21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 1.09 | -84.04% | -252 | ![]() |
8 |
27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 1.99 | -55.63% | -167 | ![]() |
8 |
12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 1.99 | -48.06% | -144 | ![]() |
7 |
11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 1.99 | -48.46% | -145 | ![]() |
4 |
10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 1.99 | -41.46% | -124 | ![]() |
7 |
Enregistrements 1 à 50 sur 61 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
16/06/21 | EUROFINS SCIENTIFIC SE | Achat | 2 000 E | 86.95 | 87.85 | 0.37% | 7 | ![]() |
6 |
14/06/21 | MANITOU GROUP | Achat | 2 000 E | 27.25 | 27.60 | 0.97% | 19 | ![]() |
2 |
14/06/21 | EUROFINS SCIENTIFIC SE | Achat | 1 000 E | 85.25 | 86.92 | 1.45% | 15 | ![]() |
6 |
04/06/21 | MANITOU GROUP | Achat | 1 000 E | 27.45 | 28.45 | 2.72% | 27 | ![]() |
3 |
04/06/21 | MANITOU GROUP | Achat | 2 000 E | 28.15 | 28.10 | -1.22% | -24 | ![]() |
3 |
03/06/21 | MANITOU GROUP | Achat | 2 000 E | 27.40 | 27.70 | 0.54% | 11 | ![]() |
3 |
31/05/21 | EUROFINS SCIENTIFIC SE | Achat | 1 000 E | 84.68 | 88.95 | 4.05% | 41 | ![]() |
6 |
31/05/21 | EUROFINS SCIENTIFIC SE | Achat | 1 000 E | 84.90 | 88.79 | 4.12% | 41 | ![]() |
6 |
26/05/21 | EUROFINS SCIENTIFIC SE | Achat | 2 000 E | 85.71 | 87.40 | 1.09% | 22 | ![]() |
3 |
24/05/21 | ACTIA GROUP | Achat | 300 E | 2.15 | 3.01 | 39.76% | 119 | ![]() |
2 |
24/05/21 | ACTIA GROUP | Achat | 300 E | 2.40 | 3.01 | 25.19% | 76 | ![]() |
2 |
20/05/21 | EUROFINS SCIENTIFIC SE | Achat | 1 000 E | 74.69 | 84.95 | 11.52% | 115 | ![]() |
6 |
13/05/21 | EUROFINS SCIENTIFIC SE | Achat | 2 000 E | 81.95 | 82.40 | 0.14% | 3 | ![]() |
6 |
06/05/21 | ACTIA GROUP | Achat | 300 E | 2.43 | 3.17 | 30.22% | 91 | ![]() |
3 |
04/05/21 | ACTIA GROUP | Achat | 300 E | 2.13 | 3.08 | 44.36% | 133 | ![]() |
2 |
04/05/21 | ACTIA GROUP | Achat | 300 E | 3.93 | 3.08 | -21.81% | -65 | ![]() |
4 |
03/05/21 | LEXIBOOK LINGUI.ELECTRO.SYST | Achat | 2 000 E | 2.88 | 3.24 | 12.12% | 242 | ![]() |
1 |
27/04/21 | INNATE PHARMA | Achat | 1 000 E | 4.07 | 3.54 | -17.05% | -171 | ![]() |
6 |
26/04/21 | GENSIGHT BIOLOGICS SA | Achat | 400 E | 7.95 | 8.23 | 3.32% | 13 | ![]() |
7 |
26/04/21 | GENSIGHT BIOLOGICS SA | Achat | 400 E | 8.00 | 8.21 | 2.42% | 10 | ![]() |
5 |
23/04/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.17 | 1.55 | 32.25% | 97 | ![]() |
6 |
23/04/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.31 | 1.54 | 17.34% | 52 | ![]() |
4 |
23/04/21 | INNATE PHARMA | Achat | 2 000 E | 3.91 | 3.52 | -11.05% | -221 | ![]() |
5 |
23/04/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.81 | 1.55 | -14.55% | -44 | ![]() |
3 |
23/04/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.00 | 1.55 | 54.75% | 164 | ![]() |
4 |
16/04/21 | EUROFINS SCIENTIFIC SE | Achat | 1 000 E | 77.81 | 88.60 | 12.44% | 124 | ![]() |
5 |
15/04/21 | MOULINVEST | Achat | 200 E | 11.35 | 12.85 | 13.00% | 26 | ![]() |
1 |
14/04/21 | MOULINVEST | Achat | 300 E | 11.40 | 12.80 | 12.07% | 36 | ![]() |
5 |
14/04/21 | MOULINVEST | Achat | 300 E | 10.85 | 12.80 | 17.75% | 53 | ![]() |
2 |
30/03/21 | ACTIA GROUP | Achat | 2 000 E | 3.42 | 3.05 | -11.66% | -233 | ![]() |
6 |
30/03/21 | ACTIA GROUP | Achat | 2 000 E | 3.34 | 3.05 | -9.20% | -184 | ![]() |
3 |
29/03/21 | MANITOU GROUP | Achat | 2 000 E | 26.65 | 28.10 | 5.14% | 103 | ![]() |
2 |
12/03/21 | INNATE PHARMA | Achat | 2 000 E | 3.84 | 3.97 | 2.95% | 59 | ![]() |
6 |
15/02/21 | MAGILLEM | Achat | 300 E | 20.40 | 20.20 | -1.18% | -4 | ![]() |
5 |
15/02/21 | MAGILLEM | Achat | 300 E | 19.80 | 20.20 | 1.82% | 5 | ![]() |
8 |
11/02/21 | MAGILLEM | Achat | 300 E | 13.00 | 20.00 | 53.59% | 161 | ![]() |
2 |
11/02/21 | MAGILLEM | Achat | 300 E | 12.20 | 20.00 | 63.67% | 191 | ![]() |
1 |
11/02/21 | MAGILLEM | Achat | 300 E | 12.10 | 20.00 | 65.02% | 195 | ![]() |
3 |
11/02/21 | MAGILLEM | Achat | 300 E | 20.40 | 20.00 | -2.16% | -6 | ![]() |
6 |
11/02/21 | MAGILLEM | Achat | 300 E | 20.40 | 20.00 | -2.16% | -6 | ![]() |
4 |
09/02/21 | TRILOGIQ SA | Achat | 300 E | 5.20 | 6.80 | 30.54% | 92 | ![]() |
3 |
09/02/21 | TRILOGIQ SA | Achat | 300 E | 5.10 | 6.80 | 33.10% | 99 | ![]() |
2 |
09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.75 | 6.80 | 0.54% | 2 | ![]() |
2 |
09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.95 | 6.80 | -2.36% | -7 | ![]() |
2 |
09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.95 | 6.80 | -2.36% | -7 | ![]() |
2 |
09/02/21 | INNATE PHARMA | Achat | 1 000 E | 4.61 | 4.04 | -14.21% | -142 | ![]() |
7 |
04/02/21 | MAGILLEM | Achat | 300 E | 14.70 | 20.00 | 35.82% | 107 | ![]() |
4 |
04/02/21 | MAGILLEM | Achat | 300 E | 14.70 | 20.00 | 35.82% | 107 | ![]() |
4 |
01/02/21 | EUROFINS SCIENTIFIC SE | Achat | 2 000 E | 67.41 | 80.49 | 17.62% | 352 | ![]() |
5 |
29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 7.65 | 8.72 | 13.77% | 41 | ![]() |
2 |
Enregistrements 451 à 500 sur 1154 |